Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Adaptive Biotechnologies Corp (ADPT)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 31.9% | 22.9% | 26.2% | 35.3% | 40.8% |
| Gross profit | 68.1% | 77.1% | 73.8% | 64.7% | 59.2% |
| Sales and marketing | 61.9% | 62.4% | 45.2% | 44.0% | 43.6% |
| Research and development | 92.2% | 118.0% | 83.1% | 70.3% | 83.2% |
| General and administrative | 48.3% | 50.4% | 35.7% | 36.7% | 41.5% |
| EBITDA | -126.3% | -146.7% | -83.0% | -78.6% | -98.4% |
| Depreciation | 7.9% | 6.9% | 7.2% | 7.7% | 10.7% |
| EBITA | -134.3% | -153.6% | -90.2% | -86.3% | -109.1% |
| Amortization of intangibles | 1.1% | 1.7% | 2.0% | 3.1% | 4.4% |
| EBIT | -135.4% | -155.3% | -92.1% | -89.4% | -113.5% |
| Pre-tax income | -134.3% | -148.6% | -80.6% | -83.4% | -111.4% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -134.3% | -148.6% | -81.8% | -83.3% | -111.0% |
|